Moneycontrol
HomeNewsIndiaArvind Kejriwal congratulates Delhi after Trump says US will use plasma therapy to treat COVID-19
Trending Topics

Arvind Kejriwal congratulates Delhi after Trump says US will use plasma therapy to treat COVID-19

US FDA has approved the use of blood plasma from recovered coronavirus patients as a treatment against the disease that has killed over 176,000 in the US

August 24, 2020 / 21:27 IST
Story continues below Advertisement
File image: Delhi CM Arvind Kejriwal

After the US Food and Drug Administration (FDA) gave emergency authorisation to use plasma therapy to treat COVID-19 patients in the US, Delhi Chief Minister Arvind Kejriwal congratulated Delhiites, saying what "Delhi did yesterday, America does today".

The Delhi government was the first to seek permission for trials of plasma therapy in April, and first to open a plasma bank in India in July, the Delhi government said in a statement.

US President Donald Trump on August 23 announced that the FDA had approved the use of blood plasma from recovered coronavirus patients as a treatment against the disease that has killed over 176,000 in the US.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show

"Today I am pleased to make a truly historic announcement, in our battle against China virus, that will save countless lives. The FDA (Food and Drug Administration) has issued an emergency use authorisation for a treatment known as convalescent plasma," Trump said.

Story continues below Advertisement

Trump described the procedure as a powerful therapy, as he appealed to Americans to come forward to donate plasma if they had recovered from Covid-19.